Skip to main content

Viking settlers of the Faroe Islands

Genetic evidence points to distinct Viking settlers of the Faroe Islands and Iceland


Geneticists have studied the distribution of Y-chromosome haplogroups on the Faroe Islands, known to have been colonized by Vikings around the year 900 CE, and compared these to distributions of haplogroups in today's Scandinavia.

They showed with novel analysis methods that the haplotype distribution in the Faroe Islands most closely resembled that in Norway and Denmark, and to a lesser extent that in Sweden, but differed from that in Iceland. They concluded that a band of Viking men from all over Scandinavia colonized the Faroe Islands, which differed in their geographical origin and genetic make-up from those who settled Iceland.

The ancient Vikings certainly had the travel bug. Between the late eighth century and approximately 1050 CE, they roamed the Atlantic in their longships all the way to Newfoundland, Labrador, and Greenland, as well as exploring the Mediterranean and continental Eurasia.

Among the places the Vikings are known to have settled were the Faroe Islands, an archipelago of 18 islands in the North Atlantic. They probably weren't the first to do so: Archaeologists have found evidence that these islands had been inhabited since approximately 300 CE, possibly by Celtic monks or others from the British Isles. But according to the Færeyinga Saga, written about 1200, a Viking chief called Grímur Kamban settled in the Faroe Islands between approximately 872 and 930 CE.

But where in Scandinavia did Grímur and his followers come from?

"Here we provide strong evidence that the Faroe Islands were colonized by a diverse group of male settlers from multiple Scandinavian populations," said Dr. Christopher Tillquist, an associate professor at the University of Louisville in Kentucky and the lead author of a new study published in Frontiers in Genetics.

Tillquist's co-authors were Dr. Allison Mann from the University of Wyoming and Dr. Eyðfinn Magnussen from the University of the Faroe Islands.

The scientists determined the genotype at 12 "short tandem repeat" (STR) loci on the Y-chromosome of 139 men from the Faroese islands of Borðoy, Streymoy, and Suðuroy. They assigned each man to the most likely haplogroup, each of which has different known distribution across today's Europe.

The researchers compared the distribution of genotypes to those found in 412 men from Norway, Sweden, Denmark, Iceland, and Ireland. This allowed them to reconstruct the source population of the Viking population founders.

Advanced analyses showed that the range of Faroese samples resembled the range of genotypes from broader Scandinavian, whereas the Icelandic genotypes were distinct.

The authors also developed a powerful innovative genetic method, called "Mutational Distance from Modal Haplotype" to analyze variation in SNPs (single-nucleotide polymorphisms) within the STRs. This allowed them to reveal a "founder effect"—traces of random loss of diversity during historical colonization by a small number of people—persisting in the genetic make-up of today's Faroese and Icelandic male populations.

"Scientists have long assumed that the Faroe Islands and Iceland were both settled by similar Norse people. Yet our novel analysis has shown that these islands were founded by men from different gene pools within Scandinavia," said Tillquist.

"One group, diverse in their Scandinavian origins, established themselves in the Faroe Islands, while another and more genetically divergent band of Vikings colonized Iceland. They have separate genetic signatures that persist to this day."

"There doesn't seem to have been any interbreeding afterwards between these two populations, despite their geographic proximity. Our results demonstrate that Viking expansion into the North Atlantic was more complex than previously thought."

"Each longship that set sail for these distant islands carried not just Vikings, but distinct genetic legacies. We can now trace these separate journeys of conquest and settlement, revealing a more nuanced story of Viking exploration than told by the history books."

Vikings, Faroe Islands, Norse settlers, Viking history, Viking Age, Faroese culture, Norse expansion, seafaring, Viking heritage, Norse mythology, Faroese archaeology, medieval Scandinavia, Viking trade, Norse farming, Viking longships, Faroese settlement, Norse exploration, Viking artifacts, Faroe Islands geography, Norse language, Viking influence, Faroe Islands history, Nordic heritage, Viking society, medieval Norse.

#Vikings, #FaroeIslands, #NorseSettlers, #VikingAge, #FaroeseCulture, #NorseExpansion, #Seafaring, #VikingHeritage, #NorseMythology, #FaroeseArchaeology, #ScandinavianHistory, #VikingTrade, #NorseFarming, #VikingLongships, #FaroeseSettlement, #NorseExploration, #VikingArtifacts, #FaroeGeography, #NorseLanguage, #VikingInfluence, #NordicHeritage, #FaroeHistory, #VikingSociety, #MedievalNorse, #NorseLegacy.

International Conference on Genetics and Genomics of Diseases 

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...